Embassy Suites by Hilton Gatlinburg Resort Set to Open in the Heart of the Great Smoky Mountains on March 15
27 févr. 2024 13h09 HE
|
Embassy Suites by Hilton Gatlinburg Resort
GATLINBURG, Tenn. and MCLEAN, Va., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Hospitality Solutions, a prominent Gatlinburg-based hotel development and management company, and Hilton (NYSE: HLT), will...
Provectus Biopharmaceuticals Announces First Quarter 2024 Conference Call
15 févr. 2024 08h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that it will host a conference call starting at 3...
Provectus Biopharmaceuticals Engages irlabs for Investor Relations Services
14 févr. 2024 08h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that it has engaged IR Labs, Inc. (“irlabs”) to...
GRIID Infrastructure Announces Plans to Double Capacity of Lenoir City, Tenn. Bitcoin Mining Operations
14 févr. 2024 06h30 HE
|
GRIID Infrastructure Inc.
CINCINNATI, Feb. 14, 2024 (GLOBE NEWSWIRE) -- GRIID Infrastructure Inc. (Nasdaq: GRDI) (“GRIID” or the “company”), a vertically integrated bitcoin mining operator, announced plans to double the...
DEEP GREEN Waste & Recycling, Inc. (DGWR) Announces Up-Listing to OTCQB Venture Market
18 janv. 2024 08h30 HE
|
Deep Green Waste & Recycling, Inc.
Saint Simons Island, Georgia, Jan. 18, 2024 (GLOBE NEWSWIRE) -- DEEP GREEN Waste & Recycling, Inc. (OTCQB: DGWR), a waste, recycling and remediation services company for commercial customers,...
Calvetti Ferguson Adds to Family Office Practice with New Partner
10 janv. 2024 07h38 HE
|
Calvetti Ferguson
Calvetti Ferguson is excited to announce a new partner in its family office practice and tax team, Chad Waldron.
Provectus Biopharmaceuticals Announces Notice of Allowance of First U.S. Patent of Rose Bengal Sodium for Use as Anticancer and Antiviral Vaccine Adjuvant
18 déc. 2023 08h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the United States Patent and Trademark Office (USPTO) has allowed patent application 17/488,430, titled...
Provectus Biopharmaceuticals Provides Updated Data on Cancer Immunotherapy PV-10 for Advanced Cutaneous Melanoma
15 nov. 2023 09h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today provided updated data from an ongoing Phase 1b/2 clinical trial of investigational cancer immunotherapy PV-10 (rose...
Provectus Biopharmaceuticals Provides Updated Data on Cancer Immunotherapy PV-10 for Metastatic Uveal Melanoma
13 nov. 2023 08h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today provided updated data from an ongoing Phase 1 clinical trial of investigational cancer immunotherapy PV-10 (rose bengal...
Provectus Biopharmaceuticals Announces Presentation of Preclinical PV-10 Vaccine Adjuvant Data at Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
06 nov. 2023 08h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that preclinical data from ongoing research on the potential use of investigational cancer immunotherapy...